rs772127913
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_006231.4(POLE):c.5912A>G(p.Asn1971Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,090 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1971K) has been classified as Uncertain significance.
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.5912A>G | p.Asn1971Ser | missense_variant | 43/49 | ENST00000320574.10 | |
POLE | XM_011534795.4 | c.5912A>G | p.Asn1971Ser | missense_variant | 43/48 | ||
POLE | XM_011534797.4 | c.4991A>G | p.Asn1664Ser | missense_variant | 35/40 | ||
POLE | XM_011534802.4 | c.2900A>G | p.Asn967Ser | missense_variant | 19/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POLE | ENST00000320574.10 | c.5912A>G | p.Asn1971Ser | missense_variant | 43/49 | 1 | NM_006231.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248984Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134776
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461858Hom.: 1 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727236
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 11, 2018 | Not observed at a significant frequency in large population cohorts (Lek 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Observed in the compound heterozygous state with POLE p.Glu1956Val in an individual reportedly presenting with a FILS-like (facial dysmorphism, immunodeficiency, livedo, and short stature) phenotype (Mestek-Boukhibar 2018). While POLE c.4444+3A>G, a leaky splice variant, has been reported as homozygous in individuals with FILS (Pachlopnik Schmid 2012, Thiffault 2015), it is not clear whether biallelic POLE missense variants result in a similar phenotype.; This variant is associated with the following publications: (PMID: 30049826) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 21, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POLE protein function. ClinVar contains an entry for this variant (Variation ID: 439278). This missense change has been observed in individual(s) with FILS (facial dysmorphism, immunodeficiency, livedo, and short stature) syndrome (PMID: 30049826). This variant is present in population databases (rs772127913, gnomAD 0.02%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1971 of the POLE protein (p.Asn1971Ser). - |
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Translational Omics - GOSgene, University College London | Mar 16, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Nov 30, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at